Search results :

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

EXPLORE : Most Read News All News All Webcasts / CME All Cases Congress Resource Centre All Medical Resources My Personal Edition


	04/28/2008	Viruses May Play Role in Lung Cancer Development: Presented at ELCC
	06/07/2007	Cisplatin Is More Effective Than Carboplatin for Treating Non-Small-Cell Lung Cancer
	09/12/2007	Zoledronic Acid Improves Survival in Patients With Bone Metastases: Presented at WCLC
	08/07/2006	Novelos Therapeutics Obtains FDA Fast Track Designation for Nov-002 Lung Cancer Treatment
	07/14/2005	Tarceva (Erlotinib) Granted Approval in Canada for the Treatment of Advanced Non-Small Cell Lung Cancer
	12/06/2002	FDA Approves Taxotere (Docetaxel) First-Line Treatment Of Non-Small Cell Lung Cancer
	12/03/2002	FDA Approves Taxotere (Docetaxel) For First-Line Treatment Of Non-Small Cell Lung Cancer
	11/17/1999	Doxycycline Inhibits Non-Small Cell Lung Cancer Growth: Presented at DG DISPATCH - CHEST
	05/15/2001	New Generation Platinum Compound, ZD1839, Effective In Non-small Cell Lung Cancer: Presented at ASCO
	10/22/2003	Oral Gefitinib Results in Radiographic Disease Regression and Symptom Improvement in Patients with Non-Small-Cell Lung Cancer
	04/25/2002	Intraoperative Sentinel Lymph Node Mapping Improves Micrometastasis Detection In Non-Small-Cell Lung Cancer
	07/13/2009	New Staging System Developed for Non-Small Cell Lung Cancer
	06/02/2008	Cetuximab Plus Platinum-Based Therapy Sets New Standard for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Presented at ASCO
	05/01/2008	Japanese Experience Favours Adjuvant Chemotherapy For Early-Stage Non-Small-Cell Lung Cancer: Presented at ELCC
	04/11/2008	Pemetrexed Approved in Europe for Histologically-Based First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
	02/04/2008	Good Long-Term Survival Seen With Stage T4 Lung Cancer Surgery: Presented at STS
	10/23/2007	NCCN Updates Non-Small Cell Lung Cancer Guidelines
	09/25/2007	Breast Cancer Susceptibility Gene Predicts Outcome and Response to Treatment in Lung Cancer
	09/24/2007	Zoledronic Acid Boosts Survival in Lung Cancer Patients With High N-Telopeptide Levels: Presented at ECCO
	09/11/2007	Cell Cycle Proteins Correlate With Better Survival From Lung Cancer: Presented at WCLC
	06/15/2006	Results of Key Phase 2 Studies Demonstrate Progression-Free Survival Advantage for ZD6474 (Zactima) in Lung Cancer
	01/23/2006	Palliative Radiation Actually a Cure for Some Lung Cancer Patients
	09/13/2000	Pre-Treatment Optimism Does Not Affect Outcome in Lung Cancer Patients: Presented at DG DISPATCH - LUNG CANCER
	09/15/2000	Selective Tyrosine Kinase Inhibitor Shows Promise in Non-small Cell Lung Cancer: Presented at DG DISPATCH - LUNG CANCER
	03/15/2005	Avastin (Bevacizumab, rhuMAb-VEGF) Appears to Extend Life Also for Lung Cancer Patients
	09/08/2004	Data Confirm 30% 1-YEAR Survival For Gefitinib In Non-Small Cell Lung Cancer: Presented at ESR
	02/02/2004	American Society Of Clinical Oncology Recommends Gefitinib (Iressa, ZD1839) in Lung Cancer Treatment Guidelines' Update
	01/13/2004	Trastuzumab (Herceptin) Gives Disappointing Results in Lung Cancer Trial
	10/08/2001	No Benefits Yet Found When Trastuzumab Added to Chemotherapy in Non-small Cell Lung Cancer: Presented at MCHN
	03/23/1998	FDA Panel Wants Taxol Approved For Non-Small-Cell Lung Cancer
	07/18/1997	Radiotherapy For Lung Cancer -- Little And Often Is The Answer
	08/21/2003	Clinical Trials Fail to Confirm Significant Benefit of Adjuvant Chemotherapy Following Resection in Non-Small Cell Lung Cancer: Presented at WCLC
	08/20/2003	Pemetrexed Less Toxic than Docetaxel for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Presented at WCLC
	06/04/2003	Adjuvant Chemotherapy Increases Survival in Non-Small Cell Lung Cancer: Presented at ASCO
	11/08/2001	IV Infusions of Vascular Endothelial Growth Factor Antibodies Fail to Halt Malignant Pleural Effusions: Presented at CHEST
	11/07/2001	Limited Surgical Approach can be used for Older Patients with Non-Small Cell Lung Cancer: Presented at CHEST
	10/24/2001	Study Shows Superior Survival with Docetaxel plus Cisplatin or Carboplatin Versus Vinorelbine/Cisplatin in Non-small Cell Lung Cancer: Presented at Ecco11
	05/26/2003	Irinotecan Ifosfamide Combination Shows Favourable Toxicity
	02/07/2002	Elderly Patients Respond to Platinum-Based Chemotherapy For Lung Cancer
	09/30/2009	Adding Tegafur-Uracil to Surgery Improves Survival in Patients With Stage IA-T1a NSCLC: Presented at ECCO-ESMO
	08/03/2009	Gefitinib Superior to Docetaxel in Asian Patients With Pretreated Advanced NSCLC: Presented at WCLC
	05/07/2009	Different Survival Prognoses Provided by Histological Subtypes of NSCLC That Progress to Brain Metastasis: Presented at EMCTO
	05/05/2009	Docetaxel/Oxaliplatin Effective as Second-Line Treatment in Patients With NSCLC: Presented at EMCTO
	05/05/2009	Adding Lapatinib to Chemotherapy Improves Survival in Patients With NSCLC: Presented at EMCTO
	10/28/2008	PF-00299804 Shows Preliminary Efficacy in Treating Non-Small-Cell Lung Cancer: Presented at EORTC-NCI-AACR
	10/24/2008	BMS-690514 Demonstrates Disease Control in Patients With Non-Small-Cell Lung Cancer: Presented at EORTC-NCI-AACR
	09/15/2008	Gefitinib Promising for Treatment of Non-Small-Cell Lung Cancer: Presented at ESMO
	06/17/2008	Radiofrequency Ablation Proves Effective in Treating Malignant Lung Tumours
	02/19/2008	Phase 3 Trial of Sorafenib in Patients With Non-Small-Cell Lung Cancer Halted
	09/10/2007	Antigen Makes Promising Target for Anti-Tumor Therapy: Presented at WCLC